Drugs / COR-1004
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07229118 | Nov 2025 → Jul 2026 overdue | hyperlipidemia | Corsera Health | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COR-1004 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07229118 ↗ |
| Route | Subcutaneous | “COR-1004 administered by subcutaneous (SC) injection” NCT07229118 ↗ |